Schedule 13D ownership disclosure

CYCLERION THERAPEUTICS INC

Security class unavailable · CUSIP: 23255M105

Event date: 2023-03-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,219,658
Percent of class
9.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-040535
Form type
SC 13D/A
Filer
Cyclerion Therapeutics, Inc.
CIK
CIK 1755237
Filed
Apr 03, 2023
Reporting period
Mar 31, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub